0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Equine Chorionic Gonadotropin (eCG) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-30H16525
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Equine Chorionic Gonadotropin eCG Market Research Report 2024
BUY CHAPTERS

Global Equine Chorionic Gonadotropin (eCG) Market Research Report 2025

Code: QYRE-Auto-30H16525
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Equine Chorionic Gonadotropin (eCG) Market

The global market for Equine Chorionic Gonadotropin (eCG) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. It is a glycoprotein hormone secreted by fetal-origin trophoblastic epithelial cells that form the endometrial cups.
North American market for Equine Chorionic Gonadotropin (eCG) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Equine Chorionic Gonadotropin (eCG) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Equine Chorionic Gonadotropin (eCG) include MSD Animal Health, Phiphar Healthcare Limited, RayBiotech, Ceva Santé Animale, Antech, Gansu Tianqi Biological Technology, Xiamen Origin Biotech, Cixi No.2 Hormones Factory, Biorigin (Beijing) Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Equine Chorionic Gonadotropin (eCG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Chorionic Gonadotropin (eCG).
The Equine Chorionic Gonadotropin (eCG) market size, estimations, and forecasts are provided in terms of sales volume (M IU) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Equine Chorionic Gonadotropin (eCG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Chorionic Gonadotropin (eCG) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Equine Chorionic Gonadotropin (eCG) Market Report

Report Metric Details
Report Name Equine Chorionic Gonadotropin (eCG) Market
Segment by Type
  • Lyophilized Powder
  • Liquid Form
Segment by Application
  • Infertility Treatment
  • Reproduction Assistance
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MSD Animal Health, Phiphar Healthcare Limited, RayBiotech, Ceva Santé Animale, Antech, Gansu Tianqi Biological Technology, Xiamen Origin Biotech, Cixi No.2 Hormones Factory, Biorigin (Beijing) Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Equine Chorionic Gonadotropin (eCG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Equine Chorionic Gonadotropin (eCG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Equine Chorionic Gonadotropin (eCG) Market report?

Ans: The main players in the Equine Chorionic Gonadotropin (eCG) Market are MSD Animal Health, Phiphar Healthcare Limited, RayBiotech, Ceva Santé Animale, Antech, Gansu Tianqi Biological Technology, Xiamen Origin Biotech, Cixi No.2 Hormones Factory, Biorigin (Beijing) Inc.

What are the Application segmentation covered in the Equine Chorionic Gonadotropin (eCG) Market report?

Ans: The Applications covered in the Equine Chorionic Gonadotropin (eCG) Market report are Infertility Treatment, Reproduction Assistance

What are the Type segmentation covered in the Equine Chorionic Gonadotropin (eCG) Market report?

Ans: The Types covered in the Equine Chorionic Gonadotropin (eCG) Market report are Lyophilized Powder, Liquid Form

1 Equine Chorionic Gonadotropin (eCG) Market Overview
1.1 Product Definition
1.2 Equine Chorionic Gonadotropin (eCG) by Type
1.2.1 Global Equine Chorionic Gonadotropin (eCG) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lyophilized Powder
1.2.3 Liquid Form
1.3 Equine Chorionic Gonadotropin (eCG) by Application
1.3.1 Global Equine Chorionic Gonadotropin (eCG) Market Value by Application (2024 VS 2031)
1.3.2 Infertility Treatment
1.3.3 Reproduction Assistance
1.4 Global Equine Chorionic Gonadotropin (eCG) Market Size Estimates and Forecasts
1.4.1 Global Equine Chorionic Gonadotropin (eCG) Revenue 2020-2031
1.4.2 Global Equine Chorionic Gonadotropin (eCG) Sales 2020-2031
1.4.3 Global Equine Chorionic Gonadotropin (eCG) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Equine Chorionic Gonadotropin (eCG) Market Competition by Manufacturers
2.1 Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Equine Chorionic Gonadotropin (eCG), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Product Type & Application
2.7 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Date of Enter into This Industry
2.8 Global Equine Chorionic Gonadotropin (eCG) Market Competitive Situation and Trends
2.8.1 Global Equine Chorionic Gonadotropin (eCG) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Equine Chorionic Gonadotropin (eCG) Players Market Share by Revenue
2.8.3 Global Equine Chorionic Gonadotropin (eCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Equine Chorionic Gonadotropin (eCG) Market Scenario by Region
3.1 Global Equine Chorionic Gonadotropin (eCG) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Equine Chorionic Gonadotropin (eCG) Sales by Region: 2020-2031
3.2.1 Global Equine Chorionic Gonadotropin (eCG) Sales by Region: 2020-2025
3.2.2 Global Equine Chorionic Gonadotropin (eCG) Sales by Region: 2026-2031
3.3 Global Equine Chorionic Gonadotropin (eCG) Revenue by Region: 2020-2031
3.3.1 Global Equine Chorionic Gonadotropin (eCG) Revenue by Region: 2020-2025
3.3.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Region: 2026-2031
3.4 North America Equine Chorionic Gonadotropin (eCG) Market Facts & Figures by Country
3.4.1 North America Equine Chorionic Gonadotropin (eCG) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Equine Chorionic Gonadotropin (eCG) Sales by Country (2020-2031)
3.4.3 North America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Equine Chorionic Gonadotropin (eCG) Market Facts & Figures by Country
3.5.1 Europe Equine Chorionic Gonadotropin (eCG) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Equine Chorionic Gonadotropin (eCG) Sales by Country (2020-2031)
3.5.3 Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Equine Chorionic Gonadotropin (eCG) Market Facts & Figures by Region
3.6.1 Asia Pacific Equine Chorionic Gonadotropin (eCG) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Equine Chorionic Gonadotropin (eCG) Sales by Region (2020-2031)
3.6.3 Asia Pacific Equine Chorionic Gonadotropin (eCG) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Equine Chorionic Gonadotropin (eCG) Market Facts & Figures by Country
3.7.1 Latin America Equine Chorionic Gonadotropin (eCG) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Equine Chorionic Gonadotropin (eCG) Sales by Country (2020-2031)
3.7.3 Latin America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Market Facts & Figures by Country
3.8.1 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Equine Chorionic Gonadotropin (eCG) Sales by Type (2020-2031)
4.1.1 Global Equine Chorionic Gonadotropin (eCG) Sales by Type (2020-2025)
4.1.2 Global Equine Chorionic Gonadotropin (eCG) Sales by Type (2026-2031)
4.1.3 Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2020-2031)
4.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Type (2020-2031)
4.2.1 Global Equine Chorionic Gonadotropin (eCG) Revenue by Type (2020-2025)
4.2.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Type (2026-2031)
4.2.3 Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Type (2020-2031)
4.3 Global Equine Chorionic Gonadotropin (eCG) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Equine Chorionic Gonadotropin (eCG) Sales by Application (2020-2031)
5.1.1 Global Equine Chorionic Gonadotropin (eCG) Sales by Application (2020-2025)
5.1.2 Global Equine Chorionic Gonadotropin (eCG) Sales by Application (2026-2031)
5.1.3 Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2020-2031)
5.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Application (2020-2031)
5.2.1 Global Equine Chorionic Gonadotropin (eCG) Revenue by Application (2020-2025)
5.2.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Application (2026-2031)
5.2.3 Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Application (2020-2031)
5.3 Global Equine Chorionic Gonadotropin (eCG) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Company Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Phiphar Healthcare Limited
6.2.1 Phiphar Healthcare Limited Company Information
6.2.2 Phiphar Healthcare Limited Description and Business Overview
6.2.3 Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.2.5 Phiphar Healthcare Limited Recent Developments/Updates
6.3 RayBiotech
6.3.1 RayBiotech Company Information
6.3.2 RayBiotech Description and Business Overview
6.3.3 RayBiotech Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 RayBiotech Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.3.5 RayBiotech Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Company Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 Antech
6.5.1 Antech Company Information
6.5.2 Antech Description and Business Overview
6.5.3 Antech Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Antech Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.5.5 Antech Recent Developments/Updates
6.6 Gansu Tianqi Biological Technology
6.6.1 Gansu Tianqi Biological Technology Company Information
6.6.2 Gansu Tianqi Biological Technology Description and Business Overview
6.6.3 Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.6.5 Gansu Tianqi Biological Technology Recent Developments/Updates
6.7 Xiamen Origin Biotech
6.7.1 Xiamen Origin Biotech Company Information
6.7.2 Xiamen Origin Biotech Description and Business Overview
6.7.3 Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.7.5 Xiamen Origin Biotech Recent Developments/Updates
6.8 Cixi No.2 Hormones Factory
6.8.1 Cixi No.2 Hormones Factory Company Information
6.8.2 Cixi No.2 Hormones Factory Description and Business Overview
6.8.3 Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.8.5 Cixi No.2 Hormones Factory Recent Developments/Updates
6.9 Biorigin (Beijing) Inc.
6.9.1 Biorigin (Beijing) Inc. Company Information
6.9.2 Biorigin (Beijing) Inc. Description and Business Overview
6.9.3 Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.9.5 Biorigin (Beijing) Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Equine Chorionic Gonadotropin (eCG) Industry Chain Analysis
7.2 Equine Chorionic Gonadotropin (eCG) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Equine Chorionic Gonadotropin (eCG) Production Mode & Process Analysis
7.4 Equine Chorionic Gonadotropin (eCG) Sales and Marketing
7.4.1 Equine Chorionic Gonadotropin (eCG) Sales Channels
7.4.2 Equine Chorionic Gonadotropin (eCG) Distributors
7.5 Equine Chorionic Gonadotropin (eCG) Customer Analysis
8 Equine Chorionic Gonadotropin (eCG) Market Dynamics
8.1 Equine Chorionic Gonadotropin (eCG) Industry Trends
8.2 Equine Chorionic Gonadotropin (eCG) Market Drivers
8.3 Equine Chorionic Gonadotropin (eCG) Market Challenges
8.4 Equine Chorionic Gonadotropin (eCG) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Equine Chorionic Gonadotropin (eCG) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Equine Chorionic Gonadotropin (eCG) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Equine Chorionic Gonadotropin (eCG) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Equine Chorionic Gonadotropin (eCG) Sales (M IU) of Key Manufacturers (2020-2025)
 Table 5. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Equine Chorionic Gonadotropin (eCG) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Equine Chorionic Gonadotropin (eCG) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Equine Chorionic Gonadotropin (eCG) Average Price (US$/IU) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Equine Chorionic Gonadotropin (eCG), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Product Type & Application
 Table 12. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Equine Chorionic Gonadotropin (eCG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Chorionic Gonadotropin (eCG) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Equine Chorionic Gonadotropin (eCG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Equine Chorionic Gonadotropin (eCG) Sales by Region (2020-2025) & (M IU)
 Table 18. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Region (2020-2025)
 Table 19. Global Equine Chorionic Gonadotropin (eCG) Sales by Region (2026-2031) & (M IU)
 Table 20. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Region (2026-2031)
 Table 21. Global Equine Chorionic Gonadotropin (eCG) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Region (2020-2025)
 Table 23. Global Equine Chorionic Gonadotropin (eCG) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Region (2026-2031)
 Table 25. North America Equine Chorionic Gonadotropin (eCG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Equine Chorionic Gonadotropin (eCG) Sales by Country (2020-2025) & (M IU)
 Table 27. North America Equine Chorionic Gonadotropin (eCG) Sales by Country (2026-2031) & (M IU)
 Table 28. North America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Equine Chorionic Gonadotropin (eCG) Sales by Country (2020-2025) & (M IU)
 Table 32. Europe Equine Chorionic Gonadotropin (eCG) Sales by Country (2026-2031) & (M IU)
 Table 33. Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Equine Chorionic Gonadotropin (eCG) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Equine Chorionic Gonadotropin (eCG) Sales by Region (2020-2025) & (M IU)
 Table 37. Asia Pacific Equine Chorionic Gonadotropin (eCG) Sales by Region (2026-2031) & (M IU)
 Table 38. Asia Pacific Equine Chorionic Gonadotropin (eCG) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Equine Chorionic Gonadotropin (eCG) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Equine Chorionic Gonadotropin (eCG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Equine Chorionic Gonadotropin (eCG) Sales by Country (2020-2025) & (M IU)
 Table 42. Latin America Equine Chorionic Gonadotropin (eCG) Sales by Country (2026-2031) & (M IU)
 Table 43. Latin America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Equine Chorionic Gonadotropin (eCG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Equine Chorionic Gonadotropin (eCG) Sales by Country (2020-2025) & (M IU)
 Table 47. Middle East and Africa Equine Chorionic Gonadotropin (eCG) Sales by Country (2026-2031) & (M IU)
 Table 48. Middle East and Africa Equine Chorionic Gonadotropin (eCG) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Equine Chorionic Gonadotropin (eCG) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Equine Chorionic Gonadotropin (eCG) Sales (M IU) by Type (2020-2025)
 Table 51. Global Equine Chorionic Gonadotropin (eCG) Sales (M IU) by Type (2026-2031)
 Table 52. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2020-2025)
 Table 53. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2026-2031)
 Table 54. Global Equine Chorionic Gonadotropin (eCG) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Equine Chorionic Gonadotropin (eCG) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Type (2020-2025)
 Table 57. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Type (2026-2031)
 Table 58. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Type (2020-2025)
 Table 59. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Type (2026-2031)
 Table 60. Global Equine Chorionic Gonadotropin (eCG) Sales (M IU) by Application (2020-2025)
 Table 61. Global Equine Chorionic Gonadotropin (eCG) Sales (M IU) by Application (2026-2031)
 Table 62. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2020-2025)
 Table 63. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2026-2031)
 Table 64. Global Equine Chorionic Gonadotropin (eCG) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Equine Chorionic Gonadotropin (eCG) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Application (2020-2025)
 Table 67. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Application (2026-2031)
 Table 68. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Application (2020-2025)
 Table 69. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Application (2026-2031)
 Table 70. MSD Animal Health Company Information
 Table 71. MSD Animal Health Description and Business Overview
 Table 72. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2020-2025)
 Table 73. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product
 Table 74. MSD Animal Health Recent Developments/Updates
 Table 75. Phiphar Healthcare Limited Company Information
 Table 76. Phiphar Healthcare Limited Description and Business Overview
 Table 77. Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2020-2025)
 Table 78. Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Product
 Table 79. Phiphar Healthcare Limited Recent Developments/Updates
 Table 80. RayBiotech Company Information
 Table 81. RayBiotech Description and Business Overview
 Table 82. RayBiotech Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2020-2025)
 Table 83. RayBiotech Equine Chorionic Gonadotropin (eCG) Product
 Table 84. RayBiotech Recent Developments/Updates
 Table 85. Ceva Santé Animale Company Information
 Table 86. Ceva Santé Animale Description and Business Overview
 Table 87. Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2020-2025)
 Table 88. Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) Product
 Table 89. Ceva Santé Animale Recent Developments/Updates
 Table 90. Antech Company Information
 Table 91. Antech Description and Business Overview
 Table 92. Antech Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2020-2025)
 Table 93. Antech Equine Chorionic Gonadotropin (eCG) Product
 Table 94. Antech Recent Developments/Updates
 Table 95. Gansu Tianqi Biological Technology Company Information
 Table 96. Gansu Tianqi Biological Technology Description and Business Overview
 Table 97. Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2020-2025)
 Table 98. Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Product
 Table 99. Gansu Tianqi Biological Technology Recent Developments/Updates
 Table 100. Xiamen Origin Biotech Company Information
 Table 101. Xiamen Origin Biotech Description and Business Overview
 Table 102. Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2020-2025)
 Table 103. Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Product
 Table 104. Xiamen Origin Biotech Recent Developments/Updates
 Table 105. Cixi No.2 Hormones Factory Company Information
 Table 106. Cixi No.2 Hormones Factory Description and Business Overview
 Table 107. Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2020-2025)
 Table 108. Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Product
 Table 109. Cixi No.2 Hormones Factory Recent Developments/Updates
 Table 110. Biorigin (Beijing) Inc. Company Information
 Table 111. Biorigin (Beijing) Inc. Description and Business Overview
 Table 112. Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2020-2025)
 Table 113. Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Product
 Table 114. Biorigin (Beijing) Inc. Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Equine Chorionic Gonadotropin (eCG) Distributors List
 Table 118. Equine Chorionic Gonadotropin (eCG) Customers List
 Table 119. Equine Chorionic Gonadotropin (eCG) Market Trends
 Table 120. Equine Chorionic Gonadotropin (eCG) Market Drivers
 Table 121. Equine Chorionic Gonadotropin (eCG) Market Challenges
 Table 122. Equine Chorionic Gonadotropin (eCG) Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Equine Chorionic Gonadotropin (eCG)
 Figure 2. Global Equine Chorionic Gonadotropin (eCG) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Equine Chorionic Gonadotropin (eCG) Market Share by Type: 2024 & 2031
 Figure 4. Lyophilized Powder Product Picture
 Figure 5. Liquid Form Product Picture
 Figure 6. Global Equine Chorionic Gonadotropin (eCG) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Equine Chorionic Gonadotropin (eCG) Market Share by Application: 2024 & 2031
 Figure 8. Infertility Treatment
 Figure 9. Reproduction Assistance
 Figure 10. Global Equine Chorionic Gonadotropin (eCG) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Equine Chorionic Gonadotropin (eCG) Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Equine Chorionic Gonadotropin (eCG) Sales (2020-2031) & (M IU)
 Figure 13. Global Equine Chorionic Gonadotropin (eCG) Average Price (US$/IU) & (2020-2031)
 Figure 14. Equine Chorionic Gonadotropin (eCG) Report Years Considered
 Figure 15. Equine Chorionic Gonadotropin (eCG) Sales Share by Manufacturers in 2024
 Figure 16. Global Equine Chorionic Gonadotropin (eCG) Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Equine Chorionic Gonadotropin (eCG) Players: Market Share by Revenue in Equine Chorionic Gonadotropin (eCG) in 2024
 Figure 18. Equine Chorionic Gonadotropin (eCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Equine Chorionic Gonadotropin (eCG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2020-2031)
 Figure 21. North America Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2020-2031)
 Figure 22. United States Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2020-2031)
 Figure 25. Europe Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Equine Chorionic Gonadotropin (eCG) Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Region (2020-2031)
 Figure 33. China Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Equine Chorionic Gonadotropin (eCG) by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Equine Chorionic Gonadotropin (eCG) by Type (2020-2031)
 Figure 52. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Equine Chorionic Gonadotropin (eCG) by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Equine Chorionic Gonadotropin (eCG) by Application (2020-2031)
 Figure 55. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Application (2020-2031)
 Figure 56. Equine Chorionic Gonadotropin (eCG) Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Spinal Needle for Surgery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37D12504
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Autonomous Ultrasound Guidance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9D20268
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Radiation Therapy Contouring Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29Q19843
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Biliary and Pancreatic Drainage Stent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27T19786
Wed Nov 19 00:00:00 UTC 2025

Add to Cart